🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Design This study is related to a multicenter, randomized, double-bli...
Status
Unknown
Location
Hunan Second People's Hospital
Start Date
2023-06-16
Trial ID
NCT05919017
Treatments Being Tested
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a debilitating c...
Status
Terminated
Location
Center for Pelvic Health at the NorthShore University HealthSystem
Start Date
2021-09-07
Trial ID
NCT04313972
Treatments Being Tested
PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Status
Completed
Location
PRA Health Sciences - Early Development Services
Start Date
2016-11-16
Trial ID
NCT02454712
Treatments Being Tested
This is an observational cohort study using administrative insurance claims...
Status
Enrolling By Invitation
Location
IBM Watson Health™ Truven Marketscan
Start Date
2020-02-01
Trial ID
NCT05503927
Treatments Being Tested
Background: Low-dose naltrexone (LDN) may be useful in managing the patholo...
Status
Unknown
Location
Parc Sanitari Sant Joan de Déu (PSSJD)
Start Date
2022-06-01
Trial ID
NCT04739995
Treatments Being Tested
The main purpose of this study is to determine if oxycodone and naltrexone ...
Status
Completed
Location
INC Research Toronto Inc.
Start Date
2013-02
Trial ID
NCT01775189
This is a study involving treatment for alcohol dependence among males of E...
Status
Completed
Location
University of Pennsylvania
Start Date
2007-12
Trial ID
NCT00817089
Treatments Being Tested
The goal of this study is to examine how the pharmacy can better optimize t...
Status
Completed
Location
Rhode Island Hospital
Start Date
2018-09-01
Trial ID
NCT03766893
This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Status
Completed
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Start Date
2017-05-05
Trial ID
NCT03078075
Treatments Being Tested
This study aims to determine if low-dose naltrexone (LDN) reduces fatigue, ...
Status
Completed
Location
Women's Health Research Institute
Start Date
2024-01-15
Trial ID
NCT05430152
Treatments Being Tested